Bone Marrow Mesenchymal Stem Cells Promote Uterine Healing by Activating the pi3k/Akt Pathway and Modulating Inflammation in Rat Models | Newswise

Bone Marrow Mesenchymal Stem Cells Promote Uterine Healing by Activating the pi3k/Akt Pathway and Modulating Inflammation in Rat Models | Newswise

BACKGROUND Newswise — Uterine injury can cause uterine scarring, leading to a series of complications that threaten women’s health. Uterine healing is a complex process, and there are currently no effective treatments. Although our previous studies have shown that bone marrow mesenchymal stem cells (BMSCs) promote uterine damage repair, the underlying mechanisms remain unclear. However,…

Read More
Anti-Trump protesters head to DC, and even Boston Common

Anti-Trump protesters head to DC, and even Boston Common

Thousands of people from around the United States rallied in the nation’s capital Saturday for women’s reproductive rights and other causes they believe are under threat from the incoming Trump administration, reprising the original Women’s March days before President-elect Donald Trump’s second inauguration. In Boston, a Woman’s March took place Saturday on the Boston Common….

Read More
Intelligent Fight: AI Enhances Cervical Cancer Detection | Newswise

Intelligent Fight: AI Enhances Cervical Cancer Detection | Newswise

Newswise — Cervical cancer remains a major health threat for women globally, with the highest incidence in developing nations. Despite the availability of preventive measures, challenges such as limited healthcare resources and inadequate screening programs continue to undermine global efforts to eliminate the disease. The World Health Organization (WHO) has set an ambitious target to…

Read More
Bone Marrow Mesenchymal Stem Cells Promote Uterine Healing by Activating the pi3k/Akt Pathway and Modulating Inflammation in Rat Models | Newswise

Researchers Resolve Uncertainty in BRCA2 Testing, | Newswise

Newswise — ROCHESTER, Minn. — Findings from a multi-institutional, international study led by researchers from the Mayo Clinic Comprehensive Cancer Center have significantly advanced the understanding of genetic alterations in the BRCA2 gene, a key player in hereditary cancer risk. The researchers completed a comprehensive functional assessment of all possible variants within the crucial DNA-binding domain of…

Read More